Talphera, Inc. (TLPH) vs Zhengye Biotechnology Holding Limited (ZYBT)

Talphera, Inc. and Zhengye Biotechnology Holding Limited are both Drug Manufacturers Specialty & Generic companies. Talphera, Inc. is the larger, with a market value of $55.5M against $44.6M — 1.2× the size. Across the 7 metrics below, Zhengye Biotechnology Holding Limited leads on 4 and Talphera, Inc. on 3.

Valuation

Metric TLPH ZYBT Drug Manufacturers Specialty & Generic median
P/E n/m — 19.25
P/S 191.48 — 2.11
P/B 5.66 n/m 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 166.32 n/m 2.73
Earnings yield (25.00%) — (4.38%)
Free cash flow yield (11.83%) 0.00% 0.00%

Profitability

Metric TLPH ZYBT Drug Manufacturers Specialty & Generic median
Gross margin 100.00% — 53.94%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (143.36%) 0.00% (0.40%)
Return on assets (69.60%) 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric TLPH ZYBT Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (73.07%) — 10.01%
EPS growth (last fiscal year) 32.00% (800.00%) 49.06%
Revenue growth, 5-year CAGR (58.55%) — 6.74%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric TLPH ZYBT Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.24 0.05
Current ratio 4.29 1.14 2.31
Net debt to EBITDA 1.50 (0.51) 0.97

Dividend

Metric TLPH ZYBT Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric TLPH ZYBT Drug Manufacturers Specialty & Generic median
Market cap 55.54m 44.59m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack